Trial No. Principal Investigator Trial Name
SCRI GU115 Babu A double-blinded, placebo-controlled, randomized Phase II study of Enzalutamide with or without the P13 kinase/MTOR Inhibitor LY3023414 in Men with Metastatic Castration Resistant Prostate Cancer
Janssen 56021927 PCR3002 Babu A Phase III randomized, placebo-controlled, double-blind study of Apalutamide plus androgen deprivation therapy (ADT) versus ADT in subjects with metastatic hormone sensitive prostate cancer (mHSPC)